The Patent Finder

Pieris Pharmaceuticals GmbH

Also on record
Records under this name other than the patents Pieris Pharmaceuticals GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.

Back to Pieris Pharmaceuticals GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,064,963Methods and Compositions for Treating Disorders
Lapsed on the fee record
Ended Sep 4, 2026 · High confidence
Lapsed on the fee recordEnded Sep 4, 2026High confidence
US 10,046,027Muteins of Tear Lipocalin and Methods for Obtaining the Same
Lapsed on the fee record
Ended Aug 14, 2026 · High confidence
Lapsed on the fee recordEnded Aug 14, 2026High confidence
US 11,382,951Methods for Preventing or Treating Certain Disorders by Inhibiting Binding of IL-4 And/Or IL-13 to Their Respective Receptors
Lapsed on the fee record
Ended Jul 12, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 12, 2026Medium confidence
US 11,382,963Engineered T Cells and Uses Therefor
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 10,016,483Methods for Preventing or Treating Certain Disorders by Inhibiting Binding of IL-4 And/Or IL-13 to Their Respective Receptors
Lapsed on the fee record
Ended Jul 10, 2026 · High confidence
Lapsed on the fee recordEnded Jul 10, 2026High confidence
US 11,345,728Novel Specific-Binding Polypeptides and Uses Thereof
Lapsed on the fee record
Ended May 31, 2026 · Medium confidence
Lapsed on the fee recordEnded May 31, 2026Medium confidence
US 7,585,940Muteins of Human Tear Lipocalin
Term ended
Term ended Feb 4, 2026 · High confidence
Term endedTerm ended Feb 4, 2026High confidence
US 11,168,119Lipocalin Muteins with Binding Affinity for LAG-3
Lapsed on the fee record
Ended Nov 9, 2025 · High confidence
Lapsed on the fee recordEnded Nov 9, 2025High confidence
US 9,751,920Muteins with Tear Lipocalin Having Affinity to Human C-Met Receptor Tyrosine Kinase and Methods for Obtaining the Same
Lapsed on the fee record
Ended Sep 5, 2025 · High confidence
Lapsed on the fee recordEnded Sep 5, 2025High confidence
US 7,691,970Muteins of a bilin-binding protein with affinity for a given target
Term ended
Term ended Jul 10, 2025 · USPTO record
Term endedTerm ended Jul 10, 2025USPTO record
10 of 40 patents shown.
Pro members see all 40.
Pro members: see all 40 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited